R J Colonno - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

R J Colonno

Showing results (71-80 of 76) with videos related to

Pageof 8

Sort By:

You have reached the last page of results.This site can display upto 76 results.

Virology|July 1, 1987

A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100V V Hamparian, R J Colonno, M K Cooney, et al.

The Journal of Infectious Diseases|October 27, 2001

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infectionR J Colonno, E V Genovesi, I Medina, et al.

Antimicrobial Agents and Chemotherapy|July 18, 2000

BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agentsB S Robinson, K A Riccardi, Y F Gong, et al.

Antiviral Therapy|February 22, 2000

Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.

Antimicrobial Agents and Chemotherapy|August 26, 2004

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.

Journal of Medicinal Chemistry|May 10, 1996

Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicityP Chen, P T Cheng, M Alam, et al.

Pageof 8

Search research articles

Showing results (71-80 of 76) with videos related to

Sort By:

Pageof 8

You have reached the last page of results.This site can display upto 76 results.

Virology|July 1, 1987

A collaborative report: rhinoviruses--extension of the numbering system from 89 to 100V V Hamparian, R J Colonno, M K Cooney, et al.

The Journal of Infectious Diseases|October 27, 2001

Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infectionR J Colonno, E V Genovesi, I Medina, et al.

Antimicrobial Agents and Chemotherapy|July 18, 2000

BMS-232632, a highly potent human immunodeficiency virus protease inhibitor that can be used in combination with other available antiretroviral agentsB S Robinson, K A Riccardi, Y F Gong, et al.

Antiviral Therapy|February 22, 2000

Stavudine resistance: an update on susceptibility following prolonged therapyP F Lin, C J González, B Griffith, et al.

Antimicrobial Agents and Chemotherapy|August 26, 2004

Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to LamivudineD J Tenney, S M Levine, R E Rose, et al.

Journal of Medicinal Chemistry|May 10, 1996

Aminodiol HIV protease inhibitors. Synthesis and structure-activity relationships of P1/P1' compounds: correlation between lipophilicity and cytotoxicityP Chen, P T Cheng, M Alam, et al.

Pageof 8